Simcere Zaiming

Haikou, China · Founded 2020 · In IPO Registration

Developer and manufacturer of innovative oncology drugs designed for treating cancer patients with unmet clinical needs. Simcere Zaiming is based in Haikou, China and was founded in 2020. Its last reported valuation was $1.2 billion in Jun 2025. It has raised $148 million.

Last reported valuation
$1.2B
Oct 2026
Priced at
—
Total raised
$148.4M
Last round
—

Who backs Simcere Zaiming?

5 investors
InvestorType
CMG SDIC FundVenture capital
Youshan CapitalOther
China Taiping InvestmentOther
Apricot Capital (Shanghai)—
Zhonghe Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Simcere Zaiming investors

5 investors are on record for Simcere Zaiming, including CMG SDIC Fund, Youshan Capital, China Taiping Investment and Apricot Capital (Shanghai).

Free account
More of Simcere Zaiming with a free account
  • ·Watch Simcere Zaiming: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Simcere Zaiming. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View